MST Kinases Monitor Actin Cytoskeletal Integrity and Signal via c-Jun N-Terminal Kinase Stress-Activated Kinase To Regulate p21Waf1/Cip1 Stability
暂无分享,去创建一个
Walter Kolch | Eric O'Neill | Michael F. Olson | W. Kolch | E. O’Neill | K. Anderson | M. Olson | J. Munro | Kurt Anderson | R. Densham | Ruth M. Densham | June Munro | Ireen König | Ireen König
[1] Till Bretschneider,et al. Subsecond reorganization of the actin network in cell motility and chemotaxis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Friedman,et al. The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by Phosphorylation* , 2002, The Journal of Biological Chemistry.
[3] Walter Kolch,et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. , 2007, Molecular cell.
[4] D. Mann,et al. The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability , 2006, Cell cycle.
[5] Jeng-Jong Hwang,et al. Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton. , 2009, International journal of oncology.
[6] M. Kuo,et al. Apoptotic insults to human chondrocytes induced by sodium nitroprusside are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen‐activated protein kinase kinase kinase‐1/c‐Jun N‐terminal kinase, and Bax‐Mitochondria‐Mediated caspase activation , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[7] S. Usami,et al. Regulation of stretch-induced JNK activation by stress fiber orientation. , 2006, Cellular signalling.
[8] K. Aktories,et al. Clostridium botulinum C3 ADP-ribosyltransferase. , 1992, Current topics in microbiology and immunology.
[9] Walter Kolch,et al. Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1 , 2004, Science.
[10] M. Sadeghi,et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Harvey,et al. The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network , 2007, Nature Reviews Cancer.
[12] P. Casey,et al. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. , 2004, The Journal of clinical investigation.
[13] D. Amberg,et al. The MEK kinases MEKK4/Ssk2p facilitate complexity in the stress signaling responses of diverse systems , 2007, Journal of cellular biochemistry.
[14] M. Ailenberg,et al. Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. , 2003, Biochimica et biophysica acta.
[15] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. Hunter,et al. Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.
[17] E. Sahai,et al. Purification of TAT-C3 exoenzyme. , 2006, Methods in enzymology.
[18] P. Cohen,et al. The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.
[19] G. Fenteany,et al. c-Jun N-terminal kinase regulates lamellipodial protrusion and cell sheet migration during epithelial wound closure by a gene expression-independent mechanism. , 2004, Biochemical and biophysical research communications.
[20] Shile Huang,et al. Negative Regulation of ASK1 by p21Cip1 Involves a Small Domain That Includes Serine 98 That Is Phosphorylated by ASK1 In Vivo , 2007, Molecular and Cellular Biology.
[21] Z Mishal,et al. Cerivastatin, an Inhibitor of HMG-CoA Reductase, Inhibits Urokinase/Urokinase-receptor Expression and MMP-9 Secretion by Peripheral Blood Monocytes , 2000, Thrombosis and Haemostasis.
[22] J. Soria,et al. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. , 2001, Carcinogenesis.
[23] B. Popov,et al. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. , 2000, Experimental cell research.
[24] E. Choi,et al. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases , 1996, Nature.
[25] M. Coleman,et al. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton , 2006, Oncogene.
[26] S. Sebti,et al. p21WAF1/CIP1 Is Upregulated by the Geranylgeranyltransferase I Inhibitor GGTI-298 through a Transforming Growth Factor β- and Sp1-Responsive Element: Involvement of the Small GTPase RhoA , 1998, Molecular and Cellular Biology.
[27] T. Yuzyuk,et al. The MEK kinase Ssk2p promotes actin cytoskeleton recovery after osmotic stress. , 2002, Molecular biology of the cell.
[28] R. Erikson,et al. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Amberg,et al. Requirement for the Polarisome and Formin Function in Ssk2p-Mediated Actin Recovery From Osmotic Stress in Saccharomyces cerevisiae , 2007, Genetics.
[30] M. Cipolle,et al. Active stress kinases in proliferating endothelial cells associated with cytoskeletal structures. , 2006, Endothelium : journal of endothelial cell research.
[31] A. Grollman. STRUCTURAL BASIS FOR INHIBITION OF PROTEIN SYNTHESIS BY EMETINE AND CYCLOHEXIMIDE BASED ON AN ANALOGY BETWEEN IPECAC ALKALOIDS AND GLUTARIMIDE ANTIBIOTICS* , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Soria,et al. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. , 2003, Cellular signalling.
[33] I. Spector,et al. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. , 1983, Science.
[34] E. Krebs,et al. Caspase‐mediated activation and induction of apoptosis by the mammalian Ste20‐like kinase Mst1 , 1998, The EMBO journal.
[35] A. Minden,et al. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. , 2002, Oncogene.
[36] J. Chernoff,et al. Cloning and Characterization of a Human Protein Kinase with Homology to Ste20 (*) , 1995, The Journal of Biological Chemistry.
[37] E. Sahai,et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.
[38] Christopher J Marshall,et al. Ras promotes p21Waf1/Cip1 protein stability via a cyclin D1‐imposed block in proteasome‐mediated degradation , 2003, The EMBO journal.
[39] D. Gillespie,et al. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. , 2002, Cellular signalling.
[40] J. Roman,et al. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. , 2005, Cancer letters.
[41] Josep Clotet,et al. Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1 , 2004, Nature Cell Biology.
[42] Donald E Ingber,et al. A discrete cell cycle checkpoint in late G(1) that is cytoskeleton-dependent and MAP kinase (Erk)-independent. , 2002, Experimental cell research.
[43] James M. Roberts,et al. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein , 1996, The Journal of cell biology.
[44] R. M. Böhmer,et al. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. , 1996, Molecular biology of the cell.
[45] Yue Xue,et al. Association of JNK1 with p21waf1 and p53: Modulation of JNK1 activity , 2003, Molecular carcinogenesis.
[46] C. Marshall,et al. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 , 1998, Nature.
[47] A. Ashworth,et al. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 , 1995, Science.
[48] Alan Hall,et al. Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.
[49] T. Pollard,et al. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. , 1991, Biochemistry.
[50] E. Krebs,et al. Both Phosphorylation and Caspase-mediated Cleavage Contribute to Regulation of the Ste20-like Protein Kinase Mst1 during CD95/Fas-induced Apoptosis* , 2001, The Journal of Biological Chemistry.
[51] M. Bottazzi,et al. Regulation of P21cip1 Expression by Growth Factors and the Extracellular Matrix Reveals a Role for Transient ERK Activity in G1 Phase , 1999, The Journal of cell biology.
[52] B. Zuckerbraun,et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. , 2007, American journal of physiology. Cell physiology.
[53] Toshiaki Katada,et al. Activation of the c-Jun N-Terminal Kinase Pathway by MST1 Is Essential and Sufficient for the Induction of Chromatin Condensation during Apoptosis , 2007, Molecular and Cellular Biology.
[54] F. McCormick,et al. Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.
[55] S. Yonehara,et al. Phosphorylation and Dimerization Regulate Nucleocytoplasmic Shuttling of Mammalian STE20-like Kinase (MST)* , 2002, The Journal of Biological Chemistry.
[56] E. Sahai,et al. Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility , 2001, The EMBO journal.
[57] K. Ball,et al. PDK1‐dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein , 2002, The EMBO journal.
[58] K. Nehrke,et al. Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell volume. , 2006, Physiology.
[59] Wei Chen,et al. Differential regulation and properties of MAPKs , 2007, Oncogene.
[60] M. Olson,et al. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. , 2005, Current opinion in genetics & development.